Healthcare & Pharmaceuticals Blog
- Blog: Haynes and Boone BlogsProceed with Caution When Modifying Equity-Based Performance AwardsPosted on August 4, 2020 by Haynes and Boone Benefits GroupMost equity-based performance awards for employees that will vest at the end of 2020 were granted well before the COVID-19 pandemic began (in fact, many were granted two years or more before the pandemic), and none of the performance metrics for these awards likely anticipated the havoc the pandemic has caused to the companies’ financial […] The post Proceed with Caution When Modifying Equity-Based Performance Awards appeared first on Haynes and Boone Blogs.
- Blog: ALTIUS BlogsUnderstanding payment servicesPosted on July 30, 2020 by
- Blog: Antitrust UpdateImpax Oral Argument at Fifth Circuit Reveals Thorny Issues and Uncertain OutcomePosted on June 28, 2020 by Jake Walter-Warner, Amy N. Vegari, Ph.D., William F. Cavanaugh, Jr.On June 9, the United States Court of Appeals for the Fifth Circuit heard oral argument in Impax Laboratories, Inc., Etc. v. Federal Trade Commission. The appeal by pharmaceutical manufacturer Impax marks the first time a court will review the Federal Trade Commission’s (“FTC”) interpretation of the Supreme Court’s watershed decision on reverse payment settlements, [...]